バイオマーカー検査サービス市場：サービス別、技術別、疾患領域別、用途別、エンドユーザー別-2025-2030年の世界予測

バイオマーカー検査サービス市場は、2023年に9億6,490万米ドルと評価され、2024年には10億3,196万米ドルに達すると予測され、CAGR 7.34％で成長し、2030年には15億8,504万米ドルに達すると予測されています。

バイオマーカー検査サービスは、特に腫瘍学、神経学、心臓病学、感染症において、健康状態を検出、評価、モニタリングするためにバイオマーカーを利用する診断プロセスを包含します。この検査は精密医療に不可欠であり、個人の遺伝子プロファイルに合わせた治療が可能となり、多くの場合、より良い転帰につながります。バイオマーカー検査の用途は、疾患の早期診断、治療指針、予後、治療反応のモニタリングに及ぶ。同市場の主なエンドユーザーは、病院、診断研究所、研究機関、製薬会社です。主な成長要因としては、慢性疾患の増加、ゲノムおよびプロテオミクスの進歩、個別化医療への注目の高まりなどが挙げられます。特に次世代シーケンシングやデジタル化された診断法などの技術的進歩は、バイオマーカーの応用を拡大・改良する機会を提供しています。企業は、共同ブランドの診断ソリューションを開発するために、ゲノム研究機関との提携や共同開発に投資することで資本を得ることができます。

しかし、バイオマーカーの探索と検証に伴う高額なコスト、複数分析項目のアッセイに関する規制上の課題、データ管理の問題といった限界に市場は直面しています。また、包括的な解析のための標準化や多様なバイオマーカーの統合にも課題があります。革新は、自動化された統合プラットフォームによるコスト削減、データ統合戦略の強化、堅牢でスケーラブルな検証手法の開発に焦点を当てるべきです。もう一つの有望な分野は、バイオマーカー探索とデータ解釈プロセスを合理化するためのAIの統合です。この市場は非常にダイナミックであり、急速な技術進歩や付加価値サービスによる競合差別化が特徴です。この分野での成功には、共同研究の促進、先端技術への投資、規制環境の遵守に向けた戦略的アプローチが必要です。業界の動向を常に把握し、顧客中心のイノベーションを優先することが、この進化する情勢の中で市場機会を捉え、企業の成長を促進する上で極めて重要です。

市場力学：急速に進化するバイオマーカー検査サービス市場の主要市場インサイトを公開

バイオマーカー検査サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 抗がん剤開発の増加と高性能バイオマーカーの必要性
  • バイオマーカー研究に対する政府の取り組みと投資
  • バイオマーカー検査に対する財政支援の充実
• 市場抑制要因
  • バイオマーカー検査には時間とコストがかかる
• 市場機会
  • AIとMLによるバイオマーカー検査ツールと機器の進歩
  • バイオマーカー検査・分析サービスを提供するCDMOの出現
• 市場の課題
  • サンプル収集と真正性の欠如による検査の障壁

ポーターのファイブフォース：バイオマーカー検査サービス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオマーカー検査サービス市場における外部からの影響の把握

外部マクロ環境要因は、バイオマーカー検査サービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオマーカー検査サービス市場における競合情勢の把握

バイオマーカー検査サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオマーカー検査サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオマーカー検査サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオマーカー検査サービス市場における成功への道筋を描く

バイオマーカー検査サービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がん治療薬開発の増加と高性能バイオマーカーの必要性
    • バイオマーカー調査に対する政府の取り組みと投資
    • バイオマーカー検査の財政支援の利用可能性の向上
  • 抑制要因
    • バイオマーカー検査は時間と費用がかかるプロセス
  • 機会
    • AIとMLによるバイオマーカー検査ツールと機器の進歩
    • バイオマーカーの試験および分析サービスを提供する新興CDMO
  • 課題
    • サンプル収集と信頼性の欠如による検査の障壁
• 市場セグメンテーション分析
  • 技術：ポリメラーゼ連鎖反応技術の汎用性、速度、増幅能力を向上させるための継続的な進歩
  • エンドユーザー：製薬会社およびバイオテクノロジー企業による治療介入のためのバイオマーカー検査サービスの新たな利用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオマーカー検査サービス市場：サービス別

• バイオマーカーアッセイの開発と検証
• フローサイトメトリー

第7章 バイオマーカー検査サービス市場テクノロジ

• 酵素免疫測定法
• 質量分析
• 次世代シーケンシング
• ポリメラーゼ連鎖反応

第8章 バイオマーカー検査サービス市場疾患領域別

• 自己免疫疾患
• がん
• 心血管疾患
• 神経疾患

第9章 バイオマーカー検査サービス市場：用途別

• 薬の作用機序
• 薬力学的
• 予測的臨床研究
• 予後

第10章 バイオマーカー検査サービス市場：エンドユーザー別

• 契約調査機関
• 製薬・バイオテクノロジー企業
• 調査機関

第11章 南北アメリカのバイオマーカー検査サービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のバイオマーカー検査サービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのバイオマーカー検査サービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • メイヨー・クリニック・ラボラトリーズとプロジェンテックが協力し、自己免疫疾患の患者に先進的なバイオマーカー検査サービスを提供
  • 新たな前立腺がんバイオマーカー検査が米国市場に上陸
  • クアンテリックス、アルツハイマー病患者の医師による診断を支援するLucentADバイオマーカー血液検査を開始
• 戦略分析と提言

企業一覧

• Abcam PLC by Danaher Corporation
• Agilent Technologies, Inc.
• Avid Bioservices, Inc.
• Bio-Rad Laboratories, Inc.
• BioAgilytix Labs
• BiomarkerBay B. V.
• Bristol Myers Squibb
• Eurofins Scientific SE
• F. Hoffmann-La Roche AG
• Icon PLC
• Intertek Group PLC
• IQVIA
• JSR Life Sciences, LLC
• KCAS Group
• Laboratory Corporation of America Holdings
• LGC Group
• Merck KGaA
• Myriad Genetics, Inc.
• NeoGenomics Laboratories
• Parexel International Corporation
• PerkinElmer Inc.
• Randox Laboratories
• SGS S.A.
• Shuwen Biotech Co., Ltd.
• Syneos Health
• Thermo Fisher Scientific, Inc.
• WuXi Biologics Inc.

LIST OF FIGURES

• FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOMARKER TESTING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 75. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 80. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 166. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 186. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 191. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 238. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Biomarker Testing Services Market was valued at USD 964.90 million in 2023, expected to reach USD 1,031.96 million in 2024, and is projected to grow at a CAGR of 7.34%, to USD 1,585.04 million by 2030.

Biomarker testing services encompass diagnostic processes that utilize biomarkers to detect, evaluate, and monitor health conditions, particularly in oncology, neurology, cardiology, and infectious diseases. This testing is essential for precision medicine, wherein treatments can be tailored to the individual's genetic profile, often leading to better outcomes. The application of biomarker testing spans early disease diagnosis, therapeutic guidance, prognosis, and monitoring treatment response. Within the market, the primary end-users are hospitals, diagnostic laboratories, research organizations, and pharmaceutical companies. Key growth factors include the rise in chronic diseases, advancements in genomics and proteomics, and an increased focus on personalized medicine. Technological advancements, particularly in next-generation sequencing and digitalized diagnostics, present opportunities to expand and refine biomarker applications. Companies can capitalize by investing in partnerships and collaborations with genomic research entities to develop co-branded diagnostic solutions.

However, the market faces limitations such as high costs associated with biomarker discovery and validation, regulatory challenges around multi-analyte assays, and data management issues. Challenges also arise in standardization and the integration of diverse biomarker types for comprehensive analysis. Innovations should focus on reducing costs via automated and integrated platforms, enhancing data integration strategies, and developing robust, scalable validation methodologies. Another promising area is the integration of AI to streamline biomarker discovery and data interpretation processes. The market is highly dynamic, characterized by rapid technological advancements and competitive differentiation through value-added services. Success in this field requires a strategic approach towards fostering collaborations, investing in advanced technologies, and complying with regulatory environments. Staying updated with industry trends and prioritizing customer-centric innovations will be crucial to capturing market opportunities and driving company growth in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomarker Testing Services Market

The Biomarker Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing cancer drug development and need for high-performing biomarkers
  • Government initiatives and investments for biomarker research
  • Improved availability of financial coverage for biomarker testing
• Market Restraints
  • Time-consuming and expensive process of biomarker testing
• Market Opportunities
  • Advancements in biomarker testing tools & equipment with AI & ML
  • Emerging CDMOs offering biomarker testing and analysis services
• Market Challenges
  • Barriers in testing due to lack of sample collection and authenticity

Porter's Five Forces: A Strategic Tool for Navigating the Biomarker Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomarker Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomarker Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomarker Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomarker Testing Services Market

A detailed market share analysis in the Biomarker Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomarker Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomarker Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomarker Testing Services Market

A strategic analysis of the Biomarker Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Agilent Technologies, Inc., Avid Bioservices, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, KCAS Group, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, Myriad Genetics, Inc., NeoGenomics Laboratories, Parexel International Corporation, PerkinElmer Inc., Randox Laboratories, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc..

Market Segmentation & Coverage

This research report categorizes the Biomarker Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Services, market is studied across Biomarker Assay Development & Validation and Flow Cytometry.
• Based on Techonology, market is studied across Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing, and Polymerase Chain Reaction.
• Based on Disease Area, market is studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, and Neurological Disorders.
• Based on Application, market is studied across Drug Mechanism of Action, Pharmacodynamic, Predictive Clinical Studies, and Prognostic.
• Based on End-User, market is studied across Contract Research Oraganizations, Pharmaceutical & biotechnology companies, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
    • 5.1.1.2. Government initiatives and investments for biomarker research
    • 5.1.1.3. Improved availability of financial coverage for biomarker testing
  • 5.1.2. Restraints
    • 5.1.2.1. Time-consuming and expensive process of biomarker testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
    • 5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
  • 5.1.4. Challenges
    • 5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
  • 5.2.2. End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biomarker Testing Services Market, by Services

• 6.1. Introduction
• 6.2. Biomarker Assay Development & Validation
• 6.3. Flow Cytometry

7. Biomarker Testing Services Market, by Techonology

• 7.1. Introduction
• 7.2. Enzyme-Linked Immunosorbent Assay
• 7.3. Mass Spectrometry
• 7.4. Next-Generation Sequencing
• 7.5. Polymerase Chain Reaction

8. Biomarker Testing Services Market, by Disease Area

• 8.1. Introduction
• 8.2. Autoimmune Diseases
• 8.3. Cancer
• 8.4. Cardiovascular Diseases
• 8.5. Neurological Disorders

9. Biomarker Testing Services Market, by Application

• 9.1. Introduction
• 9.2. Drug Mechanism of Action
• 9.3. Pharmacodynamic
• 9.4. Predictive Clinical Studies
• 9.5. Prognostic

10. Biomarker Testing Services Market, by End-User

• 10.1. Introduction
• 10.2. Contract Research Oraganizations
• 10.3. Pharmaceutical & biotechnology companies
• 10.4. Research Institutes

11. Americas Biomarker Testing Services Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Biomarker Testing Services Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Biomarker Testing Services Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases
  • 14.3.2. Novel Prostate Cancer Biomarker Test Launches on US Market
  • 14.3.3. Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer's Disease In Patients
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC by Danaher Corporation
• 2. Agilent Technologies, Inc.
• 3. Avid Bioservices, Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. BioAgilytix Labs
• 6. BiomarkerBay B. V.
• 7. Bristol Myers Squibb
• 8. Eurofins Scientific SE
• 9. F. Hoffmann-La Roche AG
• 10. Icon PLC
• 11. Intertek Group PLC
• 12. IQVIA
• 13. JSR Life Sciences, LLC
• 14. KCAS Group
• 15. Laboratory Corporation of America Holdings
• 16. LGC Group
• 17. Merck KGaA
• 18. Myriad Genetics, Inc.
• 19. NeoGenomics Laboratories
• 20. Parexel International Corporation
• 21. PerkinElmer Inc.
• 22. Randox Laboratories
• 23. SGS S.A.
• 24. Shuwen Biotech Co., Ltd.
• 25. Syneos Health
• 26. Thermo Fisher Scientific, Inc.
• 27. WuXi Biologics Inc.